Overview
I am a specialist in pediatric critical care medicine, which means that I take care of children in the intensive care unit. Even when very sick, children are focused on the most important things to them – recovering fully so they can go back to playing and being healthy. Their remarkable resilience and sense of wonder, even during their most vulnerable and critical times, is what gets me out of bed each morning. It is a privilege to take care of children in this setting, and my pride to be able to work with them every day. My patients are children of all ages who need advanced levels of care and monitoring in the intensive care unit, and sometimes invasive therapies. This can mean anything from a child with lung disease bad enough to need a ventilator, severe infections that cause dangerously low blood pressure, or organs that no longer work and need to be supported until a transplant can be found. My job is to support and coordinate among children and families, nurses, nutritionists, physical therapists, and other specialist doctors, so that the entire team can maintain the body’s delicate balance and allow it to function during a critical illness. In addition to my clinical work, I am the director for the Pediatric Critical Care Medicine fellowship training program. Our mission is to train future leaders in clinical medicine, scientific research, and advocacy for the needs of critically ill children and their families. I take a special interest in our fellows’ development as scholars, and their understanding of statistics and epidemiology. To that end, my own research focuses on what happens to children after they recover from critical illness and go back home to their normal lives. Do they continue to develop normally? How long does it take? What other kinds of problems might occur? How can we best help with any lingering health issues? These are the kinds of questions that I am trying to answer as both a critical care doctor and scientist by using the medical record and other sources of data on children who have recovered from critical illness. Through active research and educating physicians of the future, I hope to push medical care forward and take even better care of the sickest children in the hospital.
Dr. Geneslaw is highly rated in 1 condition, according to our data. His clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C).
Dr. Geneslaw is board certified in Pediatrics. He is actively involved in clinical research, co-authoring 22 peer reviewed articles. Dr. Geneslaw is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- OTHER MEDICAID
- STATE MEDICAID
Locations
3959 Broadway, New York, NY 10032
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Nanette Silverberg is a Pediatrics provider practicing medicine in New York, New York. Dr. Silverberg is highly rated in 68 conditions, according to our data. Her clinical expertise encompasses Vitiligo, Molluscum Contagiosum, Pityriasis Alba, and Hypomelanotic Disorder.
Cardiology Consultants
Mitchell Cairo is a Pediatrics provider practicing medicine in Hawthorne, New York. Dr. Cairo is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Burkitt Lymphoma, Primary Mediastinal B-Cell Lymphoma (PMBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Transplant.
CUIMC/NewYork-Presbyterian Morgan Stanley Children's Hospital
"Monica Bhatia, MD specializes in the care of children with noncancerous blood disorders who may benefit from bone marrow transplantation, especially sickle cell anemia. She and her colleagues are working to reduce the toxicity (side effects) and complications of this treatment without compromising its effectiveness, and to make it available to more patients. The field of pediatric hematology brings with it many intellectual challenges, and bone marrow transplantation in particular is especially dynamic. Dr. Bhatia has the opportunity to provide care for the sickest children, potentially curing their disease. She builds strong relationships with her patients and their families that last for years. It is inspiring for her to see young patients grow up to lead healthy, productive lives. NewYork-Presbyterian/Morgan Stanley Children's Hospital has a robust program for bone marrow transplantation for sickle cell anemia - the only cure for this disease. Dr. Bhatia and her team have witnessed remarkable results among children who are cured with bone marrow transplantation and spared from the potentially life-threatening complications of sickle cell disease. Yet despite the advances made, only 15 percent of patients with sickle cell disease have a matched sibling bone marrow donor. Therefore, Dr. Bhatia and her team conduct research to evaluate a procedure called ""CD34-selected stem cell transplantation"" to remove T-cells from donor bone marrow for patients without a matched sibling donor. This approach reduces the risk of graft-versus-host disease (GVHD), a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach to harnessing stem cells could potentially make bone marrow transplantation a safer, effective option for many patients who are seeking a cure for sickle cell disease. Dr. Bhatia and her colleagues are currently assessing reduced-intensity transplantation, which uses lower doses of chemotherapy to decrease the risk of side effects and long-term complications without lowering the effectiveness of treatment. She is also interested in looking for ways to further improve the quality of life of patients who have had a bone marrow transplant in addition to fertility preservation.". Dr. Bhatia is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Bhatia is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Bhatia is currently accepting new patients.
Frequently Asked Questions about Dr. Andrew S. Geneslaw
Is Dr. Andrew S. Geneslaw a top-rated expert for Multisystem Inflammatory Syndrome in Children (MIS-C)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrew S. Geneslaw is classified as an Distinguished expert for Multisystem Inflammatory Syndrome in Children (MIS-C), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Andrew S. Geneslaw specialize in?
While Dr. Andrew S. Geneslaw is a Pediatrics, they have specific expertise in Multisystem Inflammatory Syndrome in Children (MIS-C). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.
Does Dr. Andrew S. Geneslaw participate in research or clinical trials?
Yes. Dr. Andrew S. Geneslaw has published 22 articles and abstracts on conditions like Multisystem Inflammatory Syndrome in Children (MIS-C). You can view a list of Dr. Andrew S. Geneslaw's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Andrew S. Geneslaw accept my insurance?
Dr. Andrew S. Geneslaw accepts most major insurance plans, including Medicaid. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multisystem Inflammatory Syndrome in Children (MIS-C)